Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Bel Fuse, Inc. (BELFA)
NASDAQInformation TechnologyHardware, Equipment & PartsSnapshot 2026-11-05
$154.76-11.15%
Close 2026-11-05 · 1-day change
NASDAQInformation TechnologyHardware, Equipment & PartsSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
11.00 → 12.39 EPS · FY ending Dec 31, 2027 · 2 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 2 to 2; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for BELFA yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Successful strategic realignment of business units | Leadership changes and strategic realignment support growth. | Intact | progress score falls below 50% or realignment stalls | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
BELFA is a growth-focused industrial technology business, with recent strength in Data Solutions and Industrials. Its long-term thesis is intact, and momentum has improved, but execution quality remains fragile and risk is elevated.
The available valuation signal labels expectations as justified, with low fragility rather than a broad combination of expensive valuation, weak execution, and turbulence. The expectations gap is negative, but the evidence does not define its scale, so the market’s specific assumptions are unclear.
Recent financial performance is strong: sales rose from $152.238 million in 2025-Q1 to $220.510 million in 2026-Q3, and gross margin increased from 39.0% in 2026-Q1 to 40.9% in 2026-Q3. The latest release points to Data Solutions and Industrials as growth contributors, though execution is mixed and earnings quality remains fragile. Near term, a guidance cut is a meaningful risk, despite a low stated miss probability and two recent earnings beats.
The multi-year view depends on continued growth across key end markets, sustained margins, and progress on business-unit realignment. A guidance cut would weaken the near-term setup, while easing rates or steadier results and guidance from sector peers could support the backdrop for technology businesses.
BELFA’s operating momentum has improved and the thesis remains intact, but fragile earnings quality and elevated risk leave execution as the key test over the next 1 to 3 years. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| The company aims to keep gross margins near 39%. |
| Intact |
| Q2 2026 gross margin falls below 38% |
Gross margin: 40.94% FY2026-Q3; GAAP. Published target: 38% to 40%. The stored target says 2026-Q2; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Nov 3, 202640.941907 percent · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of 3 supplied quarters. Management reported: ““Looking ahead, we expect a strong fourth quarter, guiding net sales of $220 million to $240 million and gross margin of 40.0% to 42.0%.” ““Bookings remained healthy, and assuming the continuation of current market conditions, we expect third-quarter 2026 sales of $205 million to $225 million and gross margin of 39% to 41%.” Gross profit was $90.281 million in 2026-Q3. Delivery assessment Nov 5, 2026 |
Q2 2026 revenue at or above $195 million | A primary condition in Bel Fuse, Inc.'s published investment case. The stated target is >=195 million USD. | Intact | Q2 2026 revenue falls below $195 million | Revenue: $220.51M FY2026-Q3; GAAP. Published target: >=195 million USD. The stored target says 2026-Q2; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Nov 3, 2026220,510,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$9.26 → $12.39 · observed estimates
$0.85B → $0.94B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $9.26 | $848,867,690 | 1 / 8 |
| 2026-07-25 | $9.26 | $848,867,690 | 1 / 8 |
| 2026-07-26 | $9.26 | $848,867,690 | 1 / 8 |
| 2026-07-27 | $9.26 | $848,867,690 | 1 / 8 |
| 2026-07-28 | $9.26 | $848,867,690 | 1 / 8 |
| 2026-07-29 | $9.26 | $848,867,690 | 1 / 8 |
| 2026-07-30 | $9.26 | $848,867,690 | 1 / 8 |
| 2026-07-31 | $9.12 | $858,889,870 | 1 / 8 |
| 2026-08-01 | $9.99 | $854,951,187 | 1 / 8 |
| 2026-08-02 | $10.63 | $868,701,187 | 1 / 8 |
| 2026-08-03 | $10.63 | $868,701,187 | 1 / 8 |
| 2026-08-04 | $8.01 | $873,903,530 | 2 / 9 |
| 2026-08-05 | $8.01 | $873,903,530 | 2 / 9 |
| 2026-08-06 | $8.01 | $873,903,530 | 2 / 9 |
| 2026-08-07 | $10.63 | $868,701,187 | 1 / 8 |
| 2026-08-08 | $8.01 | $877,570,200 | 2 / 9 |
| 2026-08-09 | $8.01 | $877,570,200 | 2 / 9 |
| 2026-08-10 | $8.01 | $877,570,200 | 2 / 9 |
| 2026-08-11 | $8.01 | $877,570,200 | 2 / 9 |
| 2026-08-12 | $8.01 | $877,570,200 | 2 / 9 |
| 2026-08-13 | $8.01 | $877,570,200 | 2 / 9 |
| 2026-08-14 | $10.63 | $868,701,187 | 1 / 8 |
| 2026-08-15 | $10.63 | $868,701,187 | 2 / 9 |
| 2026-08-16 | $10.63 | $868,701,187 | 2 / 9 |
| 2026-08-17 | $10.63 | $868,701,187 | 2 / 9 |
| 2026-08-18 | $10.63 | $868,701,187 | 2 / 9 |
| 2026-08-19 | $10.63 | $868,701,187 | 2 / 9 |
| 2026-08-20 | $10.63 | $868,701,187 | 2 / 9 |
| 2026-08-21 | $11.00 | $872,826,187 | 2 / 9 |
| 2026-08-22 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-08-23 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-08-24 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-08-25 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-08-26 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-08-27 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-08-28 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-08-29 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-08-30 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-08-31 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-01 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-02 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-03 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-04 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-05 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-06 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-07 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-08 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-09 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-10 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-11 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-12 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-13 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-14 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-15 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-16 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-17 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-18 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-19 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-20 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-21 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-22 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-23 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-24 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-25 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-26 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-27 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-28 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-29 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-09-30 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-10-01 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-10-02 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-10-03 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-10-04 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-10-05 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-10-06 | $11.00 | $872,796,345 | 2 / 9 |
| 2026-10-07 | $11.05 | $875,171,345 | 2 / 9 |
| 2026-10-08 | $11.05 | $875,171,345 | 2 / 9 |
| 2026-10-09 | $11.05 | $875,171,345 | 2 / 9 |
| 2026-10-10 | $11.05 | $875,171,345 | 2 / 9 |
| 2026-10-11 | $11.05 | $875,171,345 | 2 / 9 |
| 2026-10-12 | $11.05 | $875,171,345 | 2 / 9 |
| 2026-10-13 | $11.05 | $875,171,345 | 2 / 9 |
| 2026-10-14 | $11.05 | $875,171,345 | 2 / 9 |
| 2026-10-15 | $11.05 | $875,171,345 | 2 / 9 |
| 2026-10-16 | $11.05 | $875,171,345 | 2 / 9 |
| 2026-10-17 | $11.05 | $875,171,345 | 2 / 9 |
| 2026-10-18 | $11.05 | $875,171,345 | 2 / 9 |
| 2026-10-19 | $11.05 | $875,171,345 | 2 / 9 |
| 2026-10-20 | $11.05 | $875,171,345 | 2 / 9 |
| 2026-10-21 | $11.05 | $875,171,345 | 2 / 9 |
| 2026-10-22 | $11.05 | $875,171,345 | 2 / 9 |
| 2026-10-23 | $11.05 | $875,171,345 | 2 / 9 |
| 2026-10-24 | $11.05 | $875,171,345 | 2 / 9 |
| 2026-10-25 | $11.05 | $875,171,345 | 2 / 9 |
| 2026-10-26 | $11.05 | $875,171,345 | 2 / 9 |
| 2026-10-27 | $11.05 | $875,171,345 | 2 / 9 |
| 2026-10-28 | $11.05 | $875,171,345 | 2 / 9 |
| 2026-10-29 | $11.05 | $875,171,345 | 2 / 9 |
| 2026-10-30 | $11.87 | $906,618,822 | 2 / 9 |
| 2026-10-31 | $12.39 | $937,923,664 | 2 / 9 |
| 2026-11-01 | $12.39 | $937,923,664 | 2 / 9 |
| 2026-11-02 | $12.39 | $937,923,664 | 2 / 9 |
| 2026-11-03 | $12.39 | $937,923,664 | 2 / 9 |
| 2026-11-04 | $12.39 | $937,923,664 | 2 / 9 |
| 2026-11-05 | $12.39 | $937,923,664 | 2 / 9 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.